Biotech BridgeBio Pharma Announces Dosing of First Patient in Phase 1 Trial of BBP-671, a Potential Best-In-Class Treatment for Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA) August 18, 2022
Biotech NGM Bio Provides Business Highlights and Reports Second Quarter 2022 Financial Results August 18, 2022
Biotech Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) August 18, 2022
Biotech Recursion Receives ISS ESG Prime Rating and Plans to Participate in the Goldman Sachs Global Sustainability Forum August 18, 2022
Biotech Cocrystal Pharma Engages CRO to Conduct Phase 2a Human Challenge Influenza A Clinical Trial with Novel, Broad-Spectrum Antiviral Candidate CC-42344 August 9, 2022
Biotech Xenon Pharmaceuticals to Present at the 13th Annual Wedbush PacGrow Healthcare Conference August 9, 2022
Biotech Veru Announces Presentation of Phase 3 Study of Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome at the 11th International Conference on Emerging Infectious Diseases (ICEID) on August 7-10, 2022 August 9, 2022